Lanean...
Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema
Diabetic macular oedema (DMO) is the most common cause of visual loss in the working age population. Intravitreal therapy has superseded macular laser as the first-line treatment for the management of centre-involving DMO in most patients. As well as the proven efficacy of intravitreal anti-vascular...
Gorde:
| Argitaratua izan da: | Ther Adv Chronic Dis |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549694/ https://ncbi.nlm.nih.gov/pubmed/26336592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315590319 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|